V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210033247 | 210011040 | null | 50 | Palliative (P) | 2018-12-11 | 2018-12-22 | Bendamustine+Rituximab(Sub Courses) | N | N | 210028183 | BENDAMUSTINE + RITUXIMAB |
| 210033248 | 210011045 | 1.6 | 111.3 | Disease modification (D) | 2018-09-02 | 2018-09-03 | FCR | N | N | 210028194 | FCR |
| 210033249 | 210011048 | 1.77 | null | Palliative (P) | null | 2016-02-10 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | 210028218 | FCR |
| 210033250 | 210011080 | null | 51.3 | null | 2015-04-07 | 2015-07-01 | FLAIR Trial | N | N | 210028309 | FLAIR TRIAL |
| 210033251 | 210011081 | 1.77 | 82.3 | Disease modification (D) | 2015-04-03 | 2015-05-11 | BENDAMUSTINE + RITUXIMAB | 02 | Y | 210028320 | BENDAMUSTINE + RITUXIMAB |
| 210033252 | 210011093 | null | null | Palliative (P) | 2015-08-11 | 2015-12-24 | BENDAMUSTINE + RITUXIMAB | 2 | N | 210028382 | BENDAMUSTINE + RITUXIMAB |
| 210033253 | 210034998 | 1.79 | 88 | Disease modification (D) | 2017-08-25 | 2017-12-11 | FLAIR Trial | 01 | N | 210028415 | FLAIR TRIAL |
| 210033254 | 210011105 | null | 72.3 | Curative (C) | 2017-12-29 | 2017-12-29 | Vincristine (weekly) | N | N | 210028430 | VINCRISTINE |
| 210033255 | 210021184 | 1.18 | 69.3 | null | 2018-10-14 | 2018-10-14 | Vincristine (weekly) | null | N | 210028437 | VINCRISTINE |
| 210033256 | 210011114 | 1.54 | 72.4 | Curative (C) | 2014-09-15 | 2014-11-27 | Bendamustine+Rituximab(Sub Courses) | N | N | 210028468 | BENDAMUSTINE + RITUXIMAB |
| 210033257 | 210021190 | 1.72 | 53.95 | Curative (C) | null | 2016-03-05 | FCR Oral - Cycle 2 onwards | N | N | 210028497 | FCR |
| 210033258 | 210011128 | null | 44.7 | Palliative (P) | 2013-03-18 | 2013-07-01 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | Y | N | 210028532 | FCR |
| 210033259 | 210011130 | 1.9 | 62.3 | Palliative (P) | 2015-07-25 | 2016-08-11 | BENDAMUSTINE + RITUXIMAB | N | N | 210028533 | BENDAMUSTINE + RITUXIMAB |
| 210033260 | 210011138 | 1.6 | 58.9 | Palliative (P) | 2015-03-02 | 2015-03-02 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 210028548 | FCR |
| 210033261 | 210011152 | 1.29 | 33.5 | null | 2018-06-24 | 2018-06-24 | FCR Oral - Cycle 2 onwards | 2 | N | 210028584 | FCR |
| 210033262 | 210036101 | null | 23.25 | Not known (9) | 2013-11-25 | 2014-02-27 | FLAIR Trial | 1 | N | 210028604 | FLAIR TRIAL |
| 210033263 | 210011163 | 1.79 | 100.7 | Curative (C) | null | 2014-04-15 | FCR Oral - Cycle 2 onwards | N | N | 210028621 | FCR |
| 210033264 | 210027363 | null | 74.45 | Palliative (P) | 2014-06-16 | 2014-07-14 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 210028634 | FCR |
| 210033265 | 210011170 | 1.51 | 73.1 | Curative (C) | 2016-07-03 | 2016-07-14 | FCR Oral - Cycle 2 onwards | N | N | 210028647 | FCR |
| 210033266 | 210021217 | 1.67 | 96 | null | 2016-07-18 | 2016-09-23 | Vincristine (weekly) | N | N | 210028649 | VINCRISTINE |
| 210033267 | 210011185 | 1.62 | 86.7 | Curative (C) | 2016-03-10 | 2016-04-08 | FLAIR Trial | N | N | 210028709 | FLAIR TRIAL |
| 210033268 | 210011192 | 1.8 | 12.7 | Curative (C) | 2018-04-19 | 2018-06-01 | FLAIR Trial | 2 | N | 210028734 | FLAIR TRIAL |
| 210033269 | 210011217 | 1.83 | 134.2 | Palliative (P) | 2017-02-12 | 2018-07-14 | BENDAMUSTINE + RITUXIMAB | N | N | 210028809 | BENDAMUSTINE + RITUXIMAB |
| 210033270 | 210021241 | 1.65 | 130 | Curative (C) | null | 2013-07-15 | Bendamustine+Rituximab(Sub Courses) | N | N | 210028830 | BENDAMUSTINE + RITUXIMAB |
| 210033271 | 210011238 | null | 10.5 | Palliative (P) | 2018-07-11 | 2018-07-17 | BENDAMUSTINE + RITUXIMAB | null | null | 210028874 | BENDAMUSTINE + RITUXIMAB |
| 210033272 | 210011247 | 1.75 | 90.6 | Palliative (P) | 2017-12-19 | 2018-01-23 | FCR Oral - Cycle 2 onwards | 2 | N | 210028897 | FCR |
| 210033273 | 210011252 | 1.86 | 106.5 | null | 2018-01-05 | 2018-01-08 | FCR Oral - Cycle 2 onwards | 02 | null | 210028901 | FCR |
| 210033274 | 210011258 | 1.9 | 45 | Palliative (P) | 2014-07-04 | 2014-08-18 | VINCRISTINE | 02 | N | 210028908 | VINCRISTINE |
| 210033275 | 210021259 | 1.66 | 70.4 | Curative (C) | 2015-03-23 | 2015-07-06 | FCR Oral - Cycle 2 onwards | 02 | N | 210028914 | FCR |
| 210033276 | 210011270 | 1.79 | 87 | Disease modification (D) | 2017-08-24 | 2017-10-23 | Bendamustine+Rituximab(Sub Courses) | N | N | 210028935 | BENDAMUSTINE + RITUXIMAB |
| 210033277 | 210011274 | 1.83 | 83 | Disease modification (D) | 2018-03-11 | 2018-05-07 | FCR Oral - Cycle 2 onwards | 2 | N | 210028939 | FCR |
| 210033278 | 210011282 | 1.62 | 69.3 | Palliative (P) | 2016-10-22 | 2016-10-23 | FCR | 02 | N | 210028981 | FCR |
| 210033279 | 210011289 | 1.25 | 45.6 | Palliative (P) | 2017-05-17 | 2017-10-12 | BENDAMUSTINE + RITUXIMAB | N | N | 210029009 | BENDAMUSTINE + RITUXIMAB |
| 210033280 | 210036883 | 0 | 59.4 | Disease modification (D) | 2015-06-05 | 2015-06-20 | IDELALISIB + RITUXIMAB | Y | N | 210029077 | IDELALISIB + RITUXIMAB |
| 210033281 | 210033435 | 1.74 | 73 | Palliative (P) | 2016-06-16 | 2016-06-18 | ALL UKALL60+ TRIAL | 01 | N | 210029102 | UKALL60+ |
| 210033282 | 210011315 | 1.68 | 95.1 | Adjuvant (A) | 2016-01-03 | 2016-01-03 | IDELALISIB + RITUXIMAB | N | N | 210029159 | IDELALISIB + RITUXIMAB |
| 210033283 | 210011320 | 1.73 | 70 | Curative (C) | null | 2015-11-19 | Imatinib 400mg | N | N | 210029163 | IMATINIB |
| 210033284 | 210011325 | 1.71 | 57 | Curative (C) | 2016-07-13 | 2016-09-14 | IDELALISIB + RITUXIMAB | Y | N | 210029191 | IDELALISIB + RITUXIMAB |
| 210033285 | 210011331 | null | 57.8 | Curative (C) | null | 2019-02-26 | IDELALISIB + RITUXIMAB | N | N | 210029196 | IDELALISIB + RITUXIMAB |
| 210033286 | 210011359 | 0 | 42.5 | Curative (C) | 2017-11-07 | 2018-07-06 | IMATINIB | N | N | 210029276 | IMATINIB |
| 210033287 | 210011364 | 1.68 | 84.8 | Curative (C) | 2016-01-19 | 2016-01-20 | ALL UKALL60+ TRIAL | N | null | 210029291 | UKALL60+ |
| 210033288 | 210011386 | 1.54 | null | Curative (C) | 2017-09-09 | 2018-01-27 | IMATINIB | null | null | 210029359 | IMATINIB |
| 210033289 | 210011400 | 0 | 70 | Disease modification (D) | 2016-06-15 | 2016-07-22 | CHLORAMBUCIL + OBINUTUZUMAB | 01 | N | 210029402 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210033290 | 210011411 | null | 88.2 | Curative (C) | 2014-02-23 | 2014-03-23 | METHOTREXATE | Y | N | 210029448 | METHOTREXATE |
| 210033291 | 210011413 | null | null | Curative (C) | 2017-08-07 | 2017-08-07 | Imatinib 400mg | N | null | 210029451 | IMATINIB |
| 210033292 | 210011423 | 1.6 | 80 | Palliative (P) | 2018-12-27 | 2019-02-10 | IDELALISIB + RITUXIMAB | Y | N | 210029502 | IDELALISIB + RITUXIMAB |
| 210033293 | 210011488 | 1.51 | null | Curative (C) | 2018-03-13 | 2018-03-13 | IDELALISIB + RITUXIMAB | 2 | N | 210029804 | IDELALISIB + RITUXIMAB |
| 210033294 | 210011495 | 1.77 | 71.5 | Curative (C) | 2018-07-25 | 2018-09-22 | METHOTREXATE | N | N | 210029832 | METHOTREXATE |
| 210033295 | 210011507 | 1.75 | 77.75 | Curative (C) | 2017-01-09 | 2017-01-09 | METHOTREXATE | 02 | N | 210029884 | METHOTREXATE |
| 210033296 | 210011538 | 1.68 | 61.2 | null | 2018-10-13 | 2018-10-13 | IMATINIB | N | N | 210030000 | IMATINIB |